Public health evolutionary biology of antimicrobial resistance: Priorities for intervention

Evolutionary Applications

Volumn 8, Issue 3, 2015, Pages 223-239

  Baquero, Fernando ^a,b,c   Lanza, Val F ^a,b,c   Cantón, Rafael ^a,b,d   Coque, Teresa M ^a,b,c  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b CSIC   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Antibiotic resistance; Complex causes; Complex interventions; Emergence of antibiotic resistance; Invasion by antibiotic resistance; Occupation by antibiotic resistance; Public health evolutionary biology

Indexed keywords

EID: 84925357614     PISSN: 17524563     EISSN: 17524571     Source Type: Journal    
DOI: 10.1111/eva.12235     Document Type: Note

References (201)

1. Adrian, P. V., C. Mendrick, D. Loebenberg, P. McNicholas, K. J. Shaw, K. P. Klugman, R. S. Hare et al. 2000. Evernimicin (SCH27899) inhibits a novel ribosome target site: analysis of 23S ribosomal DNA mutants. Antimicrobial Agents and Chemotherapy 44:3101-3106.
2. Ajao, A. O., A. D. Harris, M.-C. Roghmann, J. K. Johnson, M. Zhan, J. C. McGregor, and J. P. Furuno 2011. Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and Clostridium difficile acquisition. Infection Control and Hospital Epidemiology 32:481-489.
3. Alemayehu, D., J. Quinn, J. Cook, M. Kunkel, and C. A. Knirsch 2012. A paradigm shift in drug development for treatment of rare multidrug-resistant gram-negative pathogens. Clinical Infectious Diseases 55:562-567.
4. Alexander, J., J. Chase, N. Newman, A. Porter, and J. D. Roessner 2012. Emergence as a conceptual framework for understanding scientific and technological progress. Technology Management for Emerging Technologies (PICMET), 2012 Proceedings of PICMET'12: IEEE:1286-1292.
5. Ali, Y. M., A. Hayat, B. M. Saeed, K. S. Haleem, S. Alshamrani, H. I. Kenawy, V. P. Ferreira et al. 2014. Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infection. Proceedings of the National Academy of Sciences of the United States of America 111:5301-5306.
6. Ankomah, P., and B. R. Levin 2014. Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections. Proceedings of the National Academy of Sciences of the United States of America 111:8331-8338.
7. Ashbolt, N. J., A. Amézquita, T. Backhaus, P. Borriello, and K. K. Brandt 2013. Review human health risk assessment (HHRA) for environmental development and transfer of antibiotic resistance. Environmental Health Perspectives 121:993-1001.
8. Baquero, F. 2004. From pieces to patterns: evolutionary engineering in bacterial pathogens. Nature Reviews Microbiology 2:510-518.
9. Baquero, F. 2007. Evaluation of risks and benefits of consumption of antibiotics: from individual to public health. In M. Tibayrenc, ed. Encyclopedia of Infectious Diseases, pp. 509-520. Wiley and Sons Inc, Hoboken, NJ.
10. Baquero, F. 2009. Predictions: evolutionary trajectories and planet medicine. Microbial Biotechnology 2:130-132.
11. Baquero, F., and M. C. Negri 1997. Selective compartments for resistant microorganisms in antibiotic gradients. BioEssays 19:731-736.
12. Baquero, F., and C. Nombela 2012. The microbiome as a human organ. Clinical Microbiology and Infection 18(Suppl 4):2-4.
13. Baquero, F., and R. Tobes 2013. Bloody coli: a gene cocktail in Escherichia coli O104:H4. mBio 4:e00066-13.
14. Baquero, F., M. F. Vicente, and J. C. Pérez-Diaz 1985. beta-Lactam coselection of sensitive and TEM-1 beta-lactamase-producing subpopulations in heterogeneous Escherichia coli colonies. The Journal of Antimicrobial Chemotherapy 15:151-157.
15. Baquero, F., M. C. Negri, M. I. Morosini, and J. Blázquez 1998. Selection of very small differences in bacterial evolution. International Microbiology 1:295-300.
16. Baquero, F., T. M. Coque, and R. Cantón 2002. Allodemics. The Lancet infectious Diseases 2:591-592.
17. Baquero, M.-R., A. I. Nilsson, M. C. Turrientes, D. Sandvang, J. C. Galán, J. L. Martínez, N. Frimodt-Møller et al. 2004. Polymorphic mutation frequencies in Escherichia coli: emergence of weak mutators in clinical isolates. Journal of Bacteriology 186:5538-5542.
18. Baquero, F., J.-L. Martínez, and R. Cantón 2008. Antibiotics and antibiotic resistance in water environments. Current Opinion in Biotechnology 19:260-265.
19. Baquero, F., R. Cantón, and G. Cornaglia 2010. Public health microbiology, a challenge for Europe. Clinical Microbiology and Infection 16:123-125.
20. Baquero, F., T. M. Coque, and F. de la Cruz 2011. Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance. Antimicrobial Agents and Chemotherapy 55:3649-3660.
21. Baquero, F., A. P. Tedim, and T. M. Coque 2013. Antibiotic resistance shaping multilevel population biology of bacteria. Frontiers in Microbiology 4:1-15.
22. Baquero, F., T. M. Coque, and R. Cantón 2014. Counteracting antibiotic resistance: breaking barriers among antibacterial strategies. Expert Opinion on Therapeutic Targets 18:1-11.
23. Barroso-Batista, J., A. Sousa, M. Lourenço, M.-L. Bergman, D. Sobral, J. Demengeot, K. B. Xavier et al. 2014. The first steps of adaptation of Escherichia coli to the gut are dominated by soft sweeps. PLoS Genetics 10:e1004182.
24. Bednorz, C., K. Oelgeschläger, B. Kinnemann, S. Hartmann, K. Neumann, R. Pieper, A. Bethe et al. 2013. The broader context of antibiotic resistance: zinc feed supplementation of piglets increases the proportion of multi-resistant Escherichia coli in vivo. International Journal of Medical Microbiology 303:396-403.
25. Beiko, R. G., T. J. Harlow, and M. A. Ragan 2005. Highways of gene sharing in prokaryotes. Proceedings of the National Academy of Sciences of the United States of America 102:14332-14337.
26. Berrazeg, M., S. M. Diene, L. Medjahed, P. Parola, M. Drissi, D. Raoult, and J. Rolain 2014. New Delhi metallo-beta-lactamase around the world: an eReview using Google Maps. Euro Surveillance 19:20809.
27. Björkman, J., I. Nagaev, O. G. Berg, D. Hughes, and D. I. Andersson 2000. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287:1479-1482.
28. Bleidorn, J., I. Gágyor, M. M. Kochen, K. Wegscheider, and E. Hummers-Pradier 2010. Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? - results of a randomized controlled pilot trial. BMC Medicine 8:30.
29. Boon, E., C. J. Meehan, C. Whidden, D. H.-J. Wong, M. G. I. Langille, and R. G. Beiko 2014. Interactions in the microbiome: communities of organisms and communities of genes. FEMS Microbiology Reviews 38:90-118.
30. Boumghar-Bourtchaï, L., A. Dhalluin, B. Malbruny, S. Galopin, and R. Leclercq 2009. Influence of recombination on development of mutational resistance to linezolid in Enterococcus faecalis JH2-2. Antimicrobial Agents and Chemotherapy 53:4007-4009.
31. Brown, S. P., D. M. Cornforth, and N. Mideo 2012. Evolution of virulence in opportunistic pathogens: generalism, plasticity, and control. Trends in Microbiology 20:336-342.
32. Brumbaugh, A. R., and H. L. T. Mobley 2012. Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Review of Vaccines 11:663-676.
33. Buckee, C. O., K. A. Jolley, M. Recker, B. Penman, P. Kriz, S. Gupta, and M. C. J. Maiden 2008. Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidis. Proceedings of the National Academy of Sciences of the United States of America 105:15082-15087.
34. Buffie, C. G., and E. G. Pamer 2013. Microbiota-mediated colonization resistance against intestinal pathogens. Nature Reviews Immunology 13:790-801.
35. Bush, K., P. Courvalin, G. Dantas, J. Davies, B. Eisenstein, P. Huovinen, G. A. Jacoby et al. 2011. Tackling antibiotic resistance. Nature Reviews Microbiology 9:894-896.
36. Casadevall, A. 1996. Crisis in infectious diseases: time for a new paradigm? Clinical infectious Diseases 23:790-794.
37. Centers for Disease Control and Prevention 2013. Antimicrobial resistance threats in the United States | CDC. http://www.cdc.gov/drugresistance/threat-report-2013/ (accessed on April 2013).
38. Chapleau, F., and P. H. Johansen 1988. The distinction between pattern and process in evolutionary biology: the use and abuse of the term strategy. Oikos 53:136-138.
39. Charani, E., E. Castro-Sánchez, and A. Holmes 2014. The role of behavior change in antimicrobial stewardship. Infectious Disease Clinics of North America 28:169-175.
40. Chen, L., B. Mathema, J. D. D. Pitout, F. R. DeLeo, and B. N. Kreiswirth 2014. Epidemic Klebsiella pneumoniae ST258 is a hybrid strain. mBio 5:e01355-14.
41. Clatworthy, A. E., E. Pierson, and D. T. Hung 2007. Targeting virulence: a new paradigm for antimicrobial therapy. Nature Chemical Biology 3:541-548.
42. Coffey, D. S. 1998. Self-organization, complexity and chaos: the new biology for medicine. Nature Medicine 4:882-885.
43. Corning, P. A. 2002. The re-emergence of emergence?: a venerable concept in search of a theory. Complexity 7:18-30.
44. Costello, E. K., K. Stagaman, L. Dethlefsen, B. J. M. Bohannan, and D. A. Relman 2012. The application of ecological theory toward an understanding of the human microbiome. Science 336:1255-1262.
45. Craig, P., P. Dieppe, S. Macintyre, S. Mitchie, I. Nazareth, and M. Petticrew 2008. Developing and evaluating complex interventions: the new Medical Research Council guidance. British Medical Journal 337:a1655.
46. Croucher, N. J., K. P. Klugman, and P. Klugman 2014. The emergence of bacterial hopeful monsters. mBio 5:e01550-14.
47. Da Costa, P. M., L. Loureiro, and A. J. F. Matos 2013. Transfer of multidrug-resistant bacteria between intermingled ecological niches: the interface between humans, animals and the environment. International Journal of Environmental Research and Public Health 10:278-294.
48. Daneman, N., S. Sarwar, R. A. Fowler, and B. H. Cuthbertson 2013. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. The Lancet Infectious Diseases 13:328-341.
49. Davison, H. C., M. E. J. Woolhouse, and J. C. Low 2000. What is antibiotic resistance and how can we measure it? Trends in Microbiology 8:554-559.
50. De Haan, J. 2006. How emergence arises. Ecological Complexity 3:293-301.
51. De la Cruz, F., and J. Davies 2000. Horizontal gene transfer and the origin of species: lessons from bacteria. Trends in Microbiology 8:128-133.
52. De Regt, M. J. A., R. J. L. Willems, R. J. Hené, P. D. Siersema, H. J. J. Verhaar, T. E. M. Hopmans, and M. J. M. Bonten 2010. Effects of probiotics on acquisition and spread of multiresistant enterococci. Antimicrobial Agents and Chemotherapy 54:2801-2805.
53. Del Campo, R., A. M. Sánchez-Díaz, J. Zamora, C. Torres, L. M. Cintas, E. Franco, R. Cantón et al. 2014. Individual variability in finger-to-finger transmission efficiency of Enterococcus faecium clones. Microbiologyopen 3:128-132.
54. Derde, L. P. G., B. S. Cooper, H. Goossens, S. Malhotra-Kumar, R. J. L. Willems, M. Gniadkowski, W. Hryniewicz et al. 2014. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. The Lancet Infectious Diseases 14:31-39.
55. Deris, J. B., M. Kim, Z. Zhang, H. Okano, R. Hermsen, A. Groisman, and T. Hwa 2013. The innate growth bistability and fitness landscapes of antibiotic-resistant bacteria. Science 342:1237435.
56. Dethlefsen, L., M. McFall-Ngai, and D. A. Relman 2007. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449:811-818.
57. Dethlefsen, L., S. Huse, M. L. Sogin, and D. A. Relman 2008. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biology 6:e280.
58. Dittrich-Reed, D. R., and B. M. Fitzpatrick 2013. Transgressive hybrids as hopeful monsters. Evolutionary Biology 40:310-315.
59. Djordjevic, S. P., H. W. Stokes, and P. Roy Chowdhury 2013. Mobile elements, zoonotic pathogens and commensal bacteria: conduits for the delivery of resistance genes into humans, production animals and soil microbiota. Frontiers in Microbiology 4:86.
60. Dugatkin, L. A., M. Perlin, and R. Atlas 2005. Antibiotic resistance and the evolution of group-beneficial traits. II: a metapopulation model. Journal of theoretical Biology 236:392-396.
61. Dugatkin, L. A., A. D. Dugatkin, R. M. Atlas, and M. H. Perlin 2008. Cheating on the edge. PLoS ONE 3:e2763.
62. Endler, J. A. 1980. Natural selection on color patterns in Poecilia reticulata. Evolution 34:76-91.
63. Fang, F. C., and A. Casadevall 2011. Reductionistic and holistic science. Infection and Immunity 79:1401-1404.
64. Fernandez-Lopez, R., I. Del Campo, C. Revilla, A. Cuevas, and F. de la Cruz 2014. Negative feedback and transcriptional overshooting in a regulatory network for horizontal gene transfer. PLoS Genetics 10:e1004171.
65. Forslund, K., S. Sunagawa, J. R. Kultima, D. R. Mende, M. Arumugam, A. Typas, and P. Bork 2013. Country-specific antibiotic use practices impact the human gut resistome. Genome Research 23:1163-1169.
66. Forslund, K., S. Sunagawa, L. P. Coelho, and P. Bork 2014. Metagenomic insights into the human gut resistome and the forces that shape it. BioEssays 36:316-329.
67. Forsman, A. 2014. Effects of genotypic and phenotypic variation on establishment are important for conservation, invasion, and infection biology. Proceedings of the National Academy of Sciences of the United States of America 111:302-307.
68. Fowler, T., D. Walker, and S. C. Davies 2014. The risk/benefit of predicting a post-antibiotic era: is the alarm working? Annals of the New York Academy of Sciences 1323:1-10.
69. Fraser, C., W. P. Hanage, and B. G. Spratt 2005. Neutral microepidemic evolution of bacterial pathogens. Proceedings of the National Academy of Sciences of the United States of America 102:1968-1973.
70. Freitas, A. R., C. Novais, A. P. Tedim, M. V. Francia, F. Baquero, L. Peixe, and T. M. Coque 2013. Microevolutionary events involving narrow host plasmids influences local fixation of vancomycin-resistance in Enterococcus populations. PLoS ONE 8:e60589.
71. Friis, R. H., and T. A. Sellers 2014. History and scope of Epidemiology. In R. H. Friis, and T. A. Sellers, eds. Epidemiology for Public Health Practice. 5th edn, pp. 1-53. Jones and Bartlett Learning LLC, Barlington, MA.
72. Garneau, J. E., M.-È. Dupuis, M. Villion, D. A. Romero, R. Barrangou, P. Boyaval, C. Fremaux et al. 2010. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468:67-71.
73. Garriss, G., M. K. Waldor, and V. Burrus 2009. Mobile antibiotic resistance encoding elements promote their own diversity. PLoS Genetics 5:e1000775.
74. Gaze, W. H., L. Zhang, N. A. Abdouslam, P. M. Hawkey, L. Calvo-Bado, J. Royle, H. Brown et al. 2011. Impacts of anthropogenic activity on the ecology of class 1 integrons and integron-associated genes in the environment. The ISME Journal 5:1253-1261.
75. Gaze, W. H., S. M. Krone, D. G. J. Larsson, X.-Z. Li, J. A. Robinson, P. Simonet, K. Smalla et al. 2013. Influence of humans on evolution and mobilization of environmental antibiotic resistome. Emerging infectious Diseases 19:e120871.
76. Gillings, M. R. 2013. Evolutionary consequences of antibiotic use for the resistome, mobilome and microbial pangenome. Frontiers in Microbiology 4:4.
77. Gillings, M. R., and H. W. Stokes 2012. Are humans increasing bacterial evolvability? Trends in Ecology and Evolution 27:346-352.
78. Gluckman, P., A. Beedle, and M. Hanson 2009. Principles of Evolutionary Medicine. Oxford University Press, New York.
79. Goldschmidt, R. 1933. Some aspects of evolution. Science 78:539-547.
80. Goldstein, J. 1999. Emergence as a construct: history and issues. Emergence 11:49-72.
81. Grall, N., L. Massias, T. T. Nguyen, S. Sayah-Jeanne, N. Ducrot, E. Chachaty, J. de Gunzburg et al. 2013. Oral DAV131, a charcoal-based adsorbent, inhibits intestinal colonization by β-lactam-resistant Klebsiella pneumoniae in cefotaxime-treated mice. Antimicrobial Agents and Chemotherapy 57:5423-5425.
82. Greulich, P., B. Waclaw, and R. J. Allen 2012. Mutational pathway determines whether drug gradients accelerate evolution of drug-resistant cells. Physical Review Letters 109:088101.
83. Grundmann, H. 2014. Towards a global antibiotic resistance surveillance system: a primer for a roadmap. Upsala Journal of Medical Sciences 119:87-95.
84. Händel, N., J. M. Schuurmans, Y. Feng, S. Brul, and B. H. Ter Kuile 2014. Interaction between mutations and regulation of gene expression during development of de novo antibiotic resistance. Antimicrobial Agents and Chemotherapy 58:4371-4379.
85. Hao, W., and J. D. Palmer 2012. Confounding phylogenetic influence of duplicative horizontal transfer and differential gene conversion. Mobile Genetic Elements 1:256-261.
86. He, X., Y. Tian, L. Guo, R. Lux, D. R. Zusman, and W. Shi 2010. Oral-derived bacterial flora defends its domain by recognizing and killing intruders - a molecular analysis using Escherichia coli as a model intestinal bacterium. Microbial Ecology 60:655-664.
87. Heithoff, D. M., W. R. Shimp, J. K. House, Y. Xie, B. C. Weimer, R. L. Sinsheimer, and M. J. Mahan 2012. Intraspecies variation in the emergence of hyperinfectious bacterial strains in nature. PLoS Pathogens 8:e1002647.
88. Henriques-Normark, B., and S. Normark 2014. Bacterial vaccines and antibiotic resistance. Upsala Journal of Medical Sciences 119:205-208.
89. Hermsen, R., and T. Hwa 2010. Sources and sinks: a stochastic model of evolution in heterogeneous environments. Physical Review Letters 105:248104.
90. Hermsen, R., J. B. Deris, and T. Hwa 2012. On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient. Proceedings of the National Academy of Sciences of the United States of America 109:10775-10780.
91. Holt, R. D. 2004. Temporal variation can facilitate niche evolution in harsh sink environments. The American Naturalist 164:187-200.
92. Hughes, J. M., B. K. Lohman, G. E. Deckert, E. P. Nichols, M. Settles, Z. Abdo, and E. M. Top 2012. The role of clonal interference in the evolutionary dynamics of plasmid-host adaptation. mBio 3:e00077-12.
93. Issa, N. T., S. W. Byers, and S. Dakshanamurthy 2014. Big data: the next frontier for innovation in therapeutics and healthcare. Expert Review of Clinical Pharmacology 7:293-298.
94. Jackson, R. W., B. Vinatzer, D. L. Arnold, S. Dorus, and J. Murillo 2011. The influence of the accessory genome on bacterial pathogen evolution. Mobile Genetic Elements 1:55-65.
95. Jain, K. 2007. Evolutionary dynamics of the most populated genotype on rugged fitness landscapes. Physical Review E Statistical Nonlinear and Soft Matter Physics 76:031922.
96. Jalasvuori, M., V.-P. Friman, A. Nieminen, J. K. H. Bamford, and A. Buckling 2011. Bacteriophage selection against a plasmid-encoded sex apparatus leads to the loss of antibiotic-resistance plasmids. Biology Letters 7:902-905.
97. Jamison, D. T., L. H. Summers, G. Alleyne, K. J. Arrow, S. Berkley, A. Binagwaho, F. Bustreo et al. 2013. Global health 2035: a world converging within a generation. Lancet 382:1898-1955.
98. Karesh, W. B., A. Dobson, J. O. Lloyd-Smith, J. Lubroth, M. A. Dixon, M. Bennett, S. Aldrich et al. 2012. Ecology of zoonoses: natural and unnatural histories. Lancet 380:1936-1945.
99. Knapp, C. W., J. Dolfing, P. A. I. Ehlert, and D. W. Graham 2010. Evidence of increasing antibiotic resistance gene abundances in archived soils since 1940. Environmental Science and Technology 44:580-587.
100. Knapp, C. W., S. M. McCluskey, B. K. Singh, C. D. Campbell, G. Hudson, and D. W. Graham 2011. Antibiotic resistance gene abundances correlate with metal and geochemical conditions in archived Scottish soils. PLoS ONE 6:e27300.
101. Knöppel, A., P. A. Lind, U. Lustig, J. Näsvall, and D. I. Andersson 2014. Minor fitness costs in an experimental model of horizontal gene transfer in bacteria. Molecular Biology and Evolution 31:1220-1227.
102. Kollef, M. H. 2006. Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit? Clinical Infectious Diseases 43(Suppl 2):S82-S88.
103. Konstan, M. W. 2008. Ibuprofen therapy for cystic fibrosis lung disease: revisited. Current Opinion in Pulmonary Medicine 14:567-573.
104. Konstan, M. W., P. J. Byard, C. L. Hoppel, and P. Davis 1995. Effect of high-dose ibuprofen in patients with cystic fibrosis. The New England Journal of Medicine 332:848-885.
105. Kothari, C., R. Gaind, L. C. Singh, A. Sinha, V. Kumari, S. Arya, H. Chellani et al. 2013. Community acquisition of β-lactamase producing Enterobacteriaceae in neonatal gut. BMC Microbiology 13:136.
106. Król, J. E., A. J. Wojtowicz, L. M. Rogers, H. Heuer, K. Smalla, S. M. Krone, and E. M. Top 2013. Invasion of E. coli biofilms by antibiotic resistance plasmids. Plasmid 70:110-119.
107. Kümmerer, K., and A. Henninger 2003. Promoting resistance by the emission of antibiotics from hospitals and households into effluent. Clinical Microbiology and Infection 9:1203-1214.
108. Kyaw, M. H., R. Lynfield, W. Schaffner, A. S. Craig, J. Hadler, A. Reingold, A. R. Thomas et al. 2006. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. The New England Journal of Medicine 354:1455-1463.
109. Laxminarayan, R., A. Duse, C. Wattal, A. K. M. Zaidi, H. F. L. Wertheim, N. Sumpradit, E. Vlieghe et al. 2013. Antibiotic resistance-the need for global solutions. The Lancet Infectious Diseases 13:1057-1098.
110. Levin, B. R., J. Antonovics, and H. Sharma 1988. Frequency-dependent selection in bacterial populations [and discussion]. Philosophical Transactions of the Royal Society of London B: Biological Sciences 319:459-472.
111. Levy, S. B. 2002. The Antibiotic Paradox: How the Misuse of Antibiotics Destroys Their Curative Powers. Da Capo Press, New York.
112. Lin, W.-T., C. Hsieh, and T. Miki 2013. Difference in [corrected] adaptive dispersal ability can promote species coexistence in fluctuating environments. PLoS ONE 8:e55218.
113. Linares, J. F., I. Gustafsson, F. Baquero, and J. L. Martinez 2006. Antibiotics as intermicrobial signaling agents instead of weapons. Proceedings of the National Academy of Sciences of the United States of America 103:19484-19489.
114. Linnan, L., and A. Steckler 2002. Process evaluation and public health interventions: An overview. In A. Steckler, and L. Linnan, eds. Process Evaluation for Public Health Interventions and Research, pp. 1-23. Jossey-Bass, San Francisco, CA.
115. Livnat, A. 2013. Interaction-based evolution: how natural selection and nonrandom mutation work together. Biology Direct 8:24.
116. Llor, C., A. Moragas, C. Bayona, R. Morros, H. Pera, J. M. Cots, Y. Fernández et al. 2011. Effectiveness of anti-inflammatory treatment versus antibiotic therapy and placebo for patients with non-complicated acute bronchitis with purulent sputum. The BAAP Study protocol. BMC Pulmonary Medicine 11:38.
117. Looft, T., and H. K. Allen 2012. Collateral effects of antibiotics on mammalian gut microbiomes. Gut Microbes 3:463-467.
118. Losos, J. B., S. J. Arnold, G. Bejerano, E. D. Brodie, D. Hibbett, H. E. Hoekstra, D. P. Mindell et al. 2013. Evolutionary biology for the 21st century. PLoS Biology 11:e1001466.
119. Macfarlane, S. 2014. Antibiotic treatments and microbes in the gut. Environmental Microbiology 16:919-924.
120. Maltby, R., M. P. Leatham-Jensen, T. Gibson, P. S. Cohen, and T. Conway 2013. Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157:H7 in the mouse intestine. PLoS ONE 8:e53957.
121. Martínez, J. L. 2013. Bacterial pathogens: from natural ecosystems to human hosts. Environmental Microbiology 15:325-333.
122. Martínez, J. L., and F. Baquero 2014. Emergence and spread of antibiotic resistance: setting a parameter space. Upsala Journal of Medical Sciences 119:68-77.
123. Martinez, M., and P. Silley 2010. Antimicrobial drug resistance. In F. Cunningham, J. Elliot, and P. Lees, eds. Comparative and Veterinary Pharmacology. Handbook of Experimental Pharmacology, pp. 227-264. Springer, Berlin, Heidelberg.
124. Masterton, R. 2009. The new treatment paradigm and the role of carbapenems. International Journal of Antimicrobial Agents 33:105-112.
125. Maura, D., and L. Debarbieux 2011. Bacteriophages as twenty-first century antibacterial tools for food and medicine. Applied Microbiology and Biotechnology 90:851-859.
126. Mazzocchi, F. 2008. Exceeding the limits of reductionism and determinism using complexity theory. EMBO Reports 9:10-14.
127. McEwen, S. A. 2012. Quantitative human health risk assessments of antimicrobial use in animals and selection of resistance: a review of publicly available reports. Revue scientifique et Technique (International Office of Epizootics) 31:261-276.
128. McEwen, B. S., and J. C. Wingfield 2003. The concept of allostasis in biology and biomedicine. Hormones and Behavior 43:2-15.
129. McKeown, T. 1979. The Role of Medicine: Dream, Mirage or Nemesis?. Blackwell, Oxford.
130. McVicker, G., T. K. Prajsnar, A. Williams, N. L. Wagner, M. Boots, S. A. Renshaw, and S. J. Foster 2014. Clonal expansion during Staphylococcus aureus infection dynamics reveals the effect of antibiotic intervention. PLoS Pathogens 10:e1003959.
131. Meador, J. P., M. E. Caldwell, P. S. Cohen, and T. Conway 2014. Escherichia coli pathotypes occupy distinct niches in the mouse intestine. Infection and Immunity 82:1931-1938.
132. Melino, S., C. Santone, P. Di Nardo, and B. Sarkar 2014. Histatins: salivary peptides with copper(II)- and zinc(II)-binding motifs: perspectives for biomedical applications. The FEBS Journal 281:657-672.
133. Merabishvili, M., D. De Vos, G. Verbeken, A. M. Kropinski, D. Vandenheuvel, R. Lavigne, P. Wattiau et al. 2012. Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104:H4 strain from the 2011 outbreak in Germany. PLoS ONE 7:e52709.
134. Meyer, E., M. Lapatschek, A. Bechtold, G. Schwarzkopf, P. Gastmeier, and F. Schwab 2009. Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICU. Intensive Care Medicine 35:862-870.
135. Modi, S. R., H. H. Lee, C. S. Spina, and J. J. Collins 2013. Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome. Nature 499:219-222.
136. Moore, G., S. Audrey, M. Barker, L. Bond, C. Bonell, C. Cooper, W. Hardeman et al. 2014. Process evaluation in complex public health intervention studies: the need for guidance. Journal of Epidemiology and Community Health 68:101-102.
137. Muniesa, M., M. Colomer-lluch, and J. Jofre 2013. Potential impact of environmental bacteriophages in spreading antibiotic resistance genes. Future Microbiology 8:739-751.
138. Negri, M.-C., M. Lipsitch, J. Blazquez, B. R. Levin, and F. Baquero 2000. Concentration-dependent selection of small phenotypic differences in TEM beta -lactamase-mediated antibiotic resistance. Antimicrobial Agents and Chemotherapy 44:2485-2491.
139. Nesse, R. M., C. T. Bergstrom, P. T. Ellison, J. S. Flier, P. Gluckman, D. R. Govindaraju, D. Niethammer et al. 2010. Evolution in health and medicine Sackler colloquium: making evolutionary biology a basic science for medicine. Proceedings of the National Academy of Sciences of the United States of America 107(Suppl):1800-1807.
140. Nesse, R. M., D. Ganten, T. R. Gregory, and G. S. Omenn 2012. Evolutionary molecular medicine. Journal of Molecular Medicine 90:509-522.
141. Ng, K. M., J. A. Ferreyra, S. K. Higginbottom, J. B. Lynch, P. C. Kashyap, S. Gopinath, N. Naidu et al. 2013. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502:96-99.
142. Nicolle, L. E. 2014. Antimicrobial stewardship in long term care facilities: what is effective? Antimicrobial Resistance and Infection Control 3:6.
143. Novais, A., I. Comas, F. Baquero, R. Cantón, T. M. Coque, A. Moya, F. González-Candelas et al. 2010. Evolutionary trajectories of beta-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistance. PLoS Pathogens 6:e1000735.
144. Ojala, V., J. Laitalainen, and M. Jalasvuori 2013. Fight evolution with evolution: plasmid-dependent phages with a wide host range prevent the spread of antibiotic resistance. Evolutionary Applications 6:925-932.
145. Pamer, E. G. 2014. Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns. Mucosal Immunology 7:210-214.
146. Partridge, S. R. 2011. Analysis of antibiotic resistance regions in Gram-negative bacteria. FEMS Microbiology Reviews 35:820-855.
147. Partridge, S. R., and R. M. Hall 2004. Complex multiple antibiotic and mercury resistance region derived from the r-det of NR1 (R100). Antimicrobial Agents and chemotherapy 48:4250-4255.
148. Partridge, S. R., and J. R. Iredell 2012. Genetic contexts of blaNDM-1. Antimicrobial Agents and Chemotherapy 56:6065-6067.
149. Partridge, S. R., Z. Zong, and J. R. Iredell 2011. Recombination in IS26 and Tn2 in the evolution of multiresistance regions carrying blaCTX-M-15 on conjugative IncF plasmids from Escherichia coli. Antimicrobial Agents and Chemotherapy 55:4971-4978.
150. Patel, R. A., H. J. Binns, and S. T. Shulman 2004. Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era. The Journal of Pediatrics 144:68-74.
151. Perron, G. G., M. Zasloff, and G. Bell 2006. Experimental evolution of resistance to an antimicrobial peptide. Proceedings of the Royal Society of London B: Biological Sciences 273:251-256.
152. Perron, G. G., A. Gonzalez, and A. Buckling 2007. Source-sink dynamics shape the evolution of antibiotic resistance and its pleiotropic fitness cost. Proceedings of the Royal Society of London B: Biological Sciences 274:2351-2356.
153. Perron, G. G., A. R. Hall, and A. Buckling 2010. Hypermutability and compensatory adaptation in antibiotic-resistant bacteria. The American Naturalist 176:303-311.
154. Perron, G. G., S. Kryazhimskiy, D. P. Rice, and A. Buckling 2012a. Multidrug therapy and evolution of antibiotic resistance: when order matters. Applied and Environmental Microbiology 78:6137-6142.
155. Perron, G. G., A. E. G. Lee, Y. Wang, W. E. Huang, and T. G. Barraclough 2012b. Bacterial recombination promotes the evolution of multi-drug-resistance in functionally diverse populations. Proceedings of the Royal Society of London B: Biological Sciences 279:1477-1484.
156. Petticrew, M. 2011. When are complex interventions "complex"? When are simple interventions "simple"? European Journal of Public Health 21:397-398.
157. Petty, N. K., N. L. Ben Zakour, M. Stanton-Cook, E. Skippington, M. Totsika, B. M. Forde, M.-D. Phan et al. 2014. Global dissemination of a multidrug resistant Escherichia coli clone. Proceedings of the National Academy of Sciences of the United States of America 111:5694-5699.
158. Pigliucci, M. 2008. What, if anything, is an evolutionary novelty ? Philosophy of Science 75:887-898.
159. Popa, O., E. Hazkani-Covo, G. Landan, W. Martin, and T. Dagan 2011. Directed networks reveal genomic barriers and DNA repair bypasses to lateral gene transfer among prokaryotes. Genome Research 21:599-609.
160. Prammananan, T., P. Sander, B. Springer, and E. C. Bottger 1999. RecA-mediated gene conversion and aminoglycoside resistance in strains heterozygous for rRNA. Antimicrobial Agents and Chemotherapy 43:447-453.
161. Rayner, G., and T. Lang 2013. Introducing the notion of ecological public health. In G. Rayner, and T. Lang, eds. Ecological Public Health: Reshaping the Conditions for Good Health, pp. 1-38. Routledge, New York, NY.
162. Read, A. F., T. Day, and S. Huijben 2011. The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy. Proceedings of the National Academy of Sciences of the United States of America 108(Suppl):10871-10877.
163. Reeves, P. R., B. Liu, Z. Zhou, D. Li, D. Guo, Y. Ren, C. Clabots et al. 2011. Rates of mutation and host transmission for an Escherichia coli clone over 3 years. PLoS ONE 6:e26907.
164. Reznick, D. A., H. Bryga, and J. A. Endler 1990. Experimentally induced life-history evolution in a natural population. Nature 346:357-359.
165. Rizzo, L., C. Manaia, C. Merlin, T. Schwartz, C. Dagot, M. C. Ploy, I. Michael et al. 2013. Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: a review. The Science of the Total Environment 447:345-360.
166. Rolain, J. M., R. Canton, and G. Cornaglia 2012. Emergence of antibiotic resistance: need for a new paradigm. Clinical Microbiology and Infection 18:615-616.
167. Rosenthal, A. Z., and M. B. Elowitz 2012. Following evolution of bacterial antibiotic resistance in real time. Nature Genetics 44:11-13.
168. Rubin, C., T. Myers, W. Stokes, B. Dunham, S. Harris, B. Lautner, and J. Annelli 2013. Review of institute of medicine and national research council recommendations for one health initiative. Emerging infectious Diseases 19:1913-1917.
169. Sala, C. D., A. J. C. Soler-Bistué, L. Korprapun, A. Zorreguieta, and M. E. Tolmasky 2012. Inhibition of cell division induced by external guide sequences (EGS Technology) targeting ftsZ. PLoS ONE 7:e47690.
170. Santoyo, G., and D. Romero 2005. Gene conversion and concerted evolution in bacterial genomes. FEMS Microbiology Reviews 29:169-183.
171. Shanks, N., and R. A. Pyles 2007. Evolution and medicine: the long reach of "Dr. Darwin". Philosophy, Ethics, and Humanities in Medicine 2:4.
172. Simjee, S., P. Silley, H. O. Werling, and R. Bywater 2008. Potential confusion regarding the term "resistance" in epidemiological surveys. The Journal of Antimicrobial Chemotherapy 61:228-229.
173. Smillie, C. S., M. B. Smith, J. Friedman, O. X. Cordero, L. A. David, and E. J. Alm 2011. Ecology drives a global network of gene exchange connecting the human microbiome. Nature 480:241-244.
174. Smolinski, M. S., M. A. Hamburg, J. Lederberg 2003. Addressing threats: conclusions and recommendations. In: M.S. Smolinski, M.A. Hamburg, and J. Lederberg, eds. Microbial Threats to Health in the 21st Century, Emergence, Detection, and Response, pp. 149-226. Institute of Medicine of the National Academies Press (US), Washington, DC.
175. Soler Bistué, A. J. C., F. A. Martín, N. Vozza, H. Ha, J. C. Joaquín, A. Zorreguieta, and M. E. Tolmasky 2009. Inhibition of aac(6′)-Ib-mediated amikacin resistance by nuclease-resistant external guide sequences in bacteria. Proceedings of the National Academy of Sciences of the United States of America 106:13230-13235.
176. Stalder, T., O. Barraud, M. Casellas, C. Dagot, and M.-C. Ploy 2012. Integron involvement in environmental spread of antibiotic resistance. Frontiers in Microbiology 3:119.
177. Stearns, S. C. 2012. Evolutionary medicine: its scope, interest and potential. Proceedings of the Royal Society of London B: Biological Sciences 279:4305-4321.
178. Stearns, S. C., R. M. Nesse, D. Haig, and J. C. Koella 2007. Introducing evolutionary thinking for medicine. In: S. C. Stearns, and J. C. Koella, eds. Evolution in Health and Disease, 2nd edn. pp. 3-14. Oxford University Press, Oxford, UK.
179. Stokes, H. W., and M. R. Gillings 2011. Gene flow, mobile genetic elements and the recruitment of antibiotic resistance genes into Gram-negative pathogens. FEMS Microbiology Reviews 35:790-819.
180. Swithers, K. S., S. M. Soucy, and J. P. Gogarten 2012. The role of reticulate evolution in creating innovation and complexity. International Journal of Evolutionary Biology 2012:418964.
181. Szmolka, A., and B. Nagy 2013. Multidrug resistant commensal Escherichia coli in animals and its impact for public health. Frontiers in Microbiology 4:258.
182. Tamminen, M., M. Virta, R. Fani, and M. Fondi 2012. Large-scale analysis of plasmid relationships through gene-sharing networks. Molecular Biology and Evolution 29:1225-1240.
183. Toleman, M. A., and T. R. Walsh 2011. Combinatorial events of insertion sequences and ICE in Gram-negative bacteria. FEMS Microbiology Reviews 35:912-935.
184. Tomson, G., and I. Vlad 2014. The need to look at antibiotic resistance from a health systems perspective. Upsala Journal of Medical Sciences 119:117-124.
185. Toprak, E., A. Veres, J. Michel, R. Chait, D. L. Hartl, and R. Kishony 2013. Evolutionary paths to antibiotic resistance under dynamically sustained drug stress. Nature Genetics 44:101-105.
186. Toussaint, A., and M. Chandler 2012. Prokaryote genome fluidity: toward a system approach of the mobilome. Methods in Molecular Biology 804:57-80.
187. Trevathan, W. R. 2007. Evolutionary medicine. Annual Review of Anthropology 36:139-154.
188. Ubeda, C., V. Bucci, S. Caballero, A. Djukovic, N. C. Toussaint, M. Equinda, L. Lipuma et al. 2013. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infection and Immunity 81:965-973.
189. Valverde, A., F. Grill, T. M. Coque, V. Pintado, F. Baquero, R. Canton, and J. Cobo 2008. High rate of intestinal colonization with extended-spectrum-beta-Lactamase-producing organisms in household contacts of Infected Community Patients. Journal of Clinical Microbiology 46:2796-2799.
190. Van den Abbeele, P., W. Verstraete, S. El Aidy, A. Geirnaert, and T. Van de Wiele 2013. Prebiotics, faecal transplants and microbial network units to stimulate biodiversity of the human gut microbiome. Microbial Biotechnology 6:335-340.
191. Vasseur, M. V., M. Laurentie, J.-G. Rolland, A. Perrin-Guyomard, J. Henri, A. A. Ferran, P.-L. Toutain et al. 2014. Low or high doses of cefquinome targeting low or high bacterial inocula cure Klebsiella pneumoniae lung infections but differentially impact the levels of antibiotic resistance in fecal flora. Antimicrobial Agents and Chemotherapy 58:1744-1748.
192. Viana, M., R. Mancy, R. Biek, S. Cleaveland, P. C. Cross, J. O. Lloyd-Smith, and D. T. Haydon 2014. Assembling evidence for identifying reservoirs of infection. Trends in Ecology and Evolution 29:270-279.
193. Wang, S., C. Wu, J. Shen, Y. Wu, and Y. Wang 2013. Hypermutable Staphylococcus aureus strains present at high frequency in subclinical bovine mastitis isolates are associated with the development of antibiotic resistance. Veterinary Microbiology 165:410-415.
194. Wellington, E. M. H., A. B. Boxall, P. Cross, E. J. Feil, W. H. Gaze, P. M. Hawkey, A. S. Johnson-Rollings et al. 2013. The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria. The Lancet Infectious Diseases 13:155-165.
195. Werner, G. D. A., J. E. Strassmann, A. B. F. Ivens, D. J. P. Engelmoer, E. Verbruggen, D. C. Queller, R. Noë et al. 2014. Evolution of microbial markets. Proceedings of the National Academy of Sciences of the United States of America 111:1237-1244.
196. Wiedenbeck, J., and F. M. Cohan 2011. Origins of bacterial diversity through horizontal genetic transfer and adaptation to new ecological niches. FEMS Microbiology Reviews 35:957-976.
197. Yi, X., and A. M. Dean 2013. Bounded population sizes, fluctuating selection and the tempo and mode of coexistence. Proceedings of the National Academy of Sciences of the United States of America 110:16945-16950.
198. Yoon, M. Y., K.-M. Lee, Y. Yoon, J. Go, Y. Park, Y.-J. Cho, G. W. Tannock et al. 2013. Functional screening of a metagenomic library reveals operons responsible for enhanced intestinal colonization by gut commensal microbes. Applied and Environmental Microbiology 79:3829-3838.
199. Zhang, Q.-G., and A. Buckling 2012. Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms. Evolutionary Applications 5:575-582.
200. Zhang, Q., G. Lambert, D. Liao, H. Kim, K. Robin, C. Tung, N. Pourmand et al. 2011. Acceleration of emergence of bacterial antibiotic resistance in connected microenvironments. Science 333:1764-1767.
201. Zhao, X., and K. Drlica 2002. Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window. The Journal of Infectious Diseases 185:561-565.